BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 10804944)

  • 1. Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy.
    Kauli R; Zaizov R; Lazar L; Pertzelan A; Laron Z; Galatzer A; Phillip M; Yaniv Y; Cohen IJ
    Isr Med Assoc J; 2000 Feb; 2(2):158-63. PubMed ID: 10804944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Children with type I Gaucher disease: growing into adulthood with and without enzyme therapy.
    Zimran A; Abrahamov A; Elstein D
    Isr Med Assoc J; 2000 Feb; 2(2):80-1. PubMed ID: 10804921
    [No Abstract]   [Full Text] [Related]  

  • 3. Is complete catch-up possible for stunted malnourished children?
    Golden MH
    Eur J Clin Nutr; 1994 Feb; 48 Suppl 1():S58-70; discussion S71. PubMed ID: 8005092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth and sexual maturation in children with thalassemia major.
    Yesilipek MA; Bircan I; Oygür N; Ertug H; Yegin O; Güven AG
    Haematologica; 1993; 78(1):30-3. PubMed ID: 8491419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy.
    Zevin S; Abrahamov A; Hadas-Halpern I; Kannai R; Levy-Lahad E; Horowitz M; Zimran A
    Q J Med; 1993 Sep; 86(9):565-73. PubMed ID: 8255971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Natural history of intrauterine growth retardation: pubertal growth and adult height].
    Job JC; Rolland A
    Arch Fr Pediatr; 1986 May; 43(5):301-6. PubMed ID: 3778088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaucher disease--Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment.
    Erikson A
    Acta Paediatr Scand Suppl; 1986; 326():1-42. PubMed ID: 3296644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations.
    Piran S; Roberts A; Patterson MA; Amato D
    Blood Cells Mol Dis; 2009; 43(3):289-93. PubMed ID: 19793665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
    Charrow J; Dulisse B; Grabowski GA; Weinreb NJ
    Clin Genet; 2007 Mar; 71(3):205-11. PubMed ID: 17309642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [French results of enzyme replacement therapy in Gaucher's disease].
    Schaison G; Caubel I; Belmatoug N; Billette de Villemeur T; Saudubray JM
    Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF; McNeill E; Young D; Donaldson MD
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth and final height after liver transplantation during childhood.
    Scheenstra R; Gerver WJ; Odink RJ; van Soest H; Peeters PM; Verkade HJ; Sauer PJ
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):165-71. PubMed ID: 18664868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
    Tóth J; Szücs FZ; Benkö K; Maródi L
    Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): the KIGS experience.
    Trollmann R; Bakker B; Lundberg M; Doerr HG
    Pediatr Rehabil; 2006; 9(2):144-8. PubMed ID: 16449073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of asthma on growth and puberty.
    Balfour-Lynn L
    Pediatrician; 1987; 14(4):237-41. PubMed ID: 3331205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed puberty in chronic illness.
    Pozo J; Argente J
    Best Pract Res Clin Endocrinol Metab; 2002 Mar; 16(1):73-90. PubMed ID: 11987900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Earlier initiation of GH therapy does not influence adult height but enables earlier start of pubertal induction in children with multiple pituitary hormone deficiency.
    Kawai M; Momoi T; Mamada M; Yorifuji T; Nakahata T
    Clin Endocrinol (Oxf); 2004 May; 60(5):608-12. PubMed ID: 15104564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease.
    Altarescu G; Schiffmann R; Parker CC; Moore DF; Kreps C; Brady RO; Barton NW
    Blood Cells Mol Dis; 2000 Aug; 26(4):285-90. PubMed ID: 11042029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.